Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. - Archive ouverte HAL Access content directly
Journal Articles Cell Death and Differentiation Year : 2009

Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates.

(1) , (1, 2) , (3) , (1) , (1) , (1) , (1) , (4) , (1)
1
2
3
4

Abstract

Pleural fluid accumulation is a frequent clinical observation in diffuse malignant pleural mesothelioma (MPM). The cytological analysis of pleural fluid often reveals the presence of free spheroid aggregates of malignant cells, giving rise to the question of the ability of non-adherent tumor cells to resist the loss of anchorage-induced apoptosis (termed as anoikis), and to develop new tumor foci in the pleural cavity. Here, we show that MPM cells cultured under non-adherent conditions form well-organized aggregates composed of viable cells, which progressively enter in G(0). Although the PI3K/Akt, ERK and SAPK/JNK signaling pathways are activated in adherent MPM cells, loss of anchorage results in the inactivation of these pathways. By comparison, we show that the non-tumoral mesothelial cells MeT-5A enter anoikis in an SAPK/JNK-, Bim- and caspase-9-dependent pathway. The survival of MPM cells can be reversed by activating SAPK/JNK with anisomycin, according to a Bim-dependent mitochondrial pathway. Finally, our findings show that impairment of cell aggregation activates SAPK/JNK and Bim and induces anoikis. Our results underline the importance of intercellular contacts in the anoikis resistance of MPM cells.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-00388174 , version 1 (26-05-2009)

Identifiers

Cite

Julien Daubriac, Jocelyne Fleury-Feith, Laurence Kheuang, J. Galipon, A. Saint-Albin, et al.. Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates.. Cell Death and Differentiation, 2009, 16 (8), pp.1146-55. ⟨10.1038/cdd.2009.32⟩. ⟨inserm-00388174⟩
161 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More